Editas Medicine, Inc

EDIT NASDAQ
EDIT
Editas Medicine, Inc NASDAQ
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

EDIT financial statements

An in-depth look to Editas Medicine, Inc operating, investing, and financing activities

EDIT free cash flow for Q1 22 is -48.26M USD. For 2021, EDIT free cash flow was -161.29M USD and operating cash flow was -153.31M USD.

TTM
Cash from operating activities
Funds from operations
Changes in working capital
Cash from investing activities
Purchase/sale of business, net
Purchase/sale of investments, net
Capital expenditures
Other investing cash flow items, total
Cash from financing activities
Issuance/retirement of stock, net
Issuance/retirement of debt, net
Total cash dividends paid
Other financing cash flow items, total
Free cash flow